[HTML][HTML] Polymeric micellar systems—a special emphasis on “smart” drug delivery

I Negut, B Bita - Pharmaceutics, 2023 - mdpi.com
Concurrent developments in anticancer nanotechnological treatments have been observed
as the burden of cancer increases every year. The 21st century has seen a transformation in …

[HTML][HTML] Can phosphodiesterase 4 inhibitor therapy be used in respiratory diseases other than chronic obstructive pulmonary disease?

MR Goonathilake, S Waqar, S George… - Cureus, 2022 - ncbi.nlm.nih.gov
Abstract Selective phosphodiesterase 4 (PDE4) inhibitors have been extensively studied for
the treatment of various respiratory diseases due to their broad anti-inflammatory and/or …

Estratégias de Formulação com Vista à Melhoria dos Resultados Terapêuticos na Doença Pulmonar Obstrutiva Crónica: Desafios e Oportunidades

CSE da Silva - 2022 - search.proquest.com
A doença pulmonar obstrutiva crónica (DPOC) é uma doença do foro pulmonar que é
caracterizada por sintomas respiratórios persistentes, como a dispneia e a tosse, e uma …